Synopsis
0
JDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Cerata Pharmaceuticals LLP
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Doshion Polyscience
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Neelkanth MineChem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Coating Systems & Additives
Fillers, Diluents & Binders
Controlled & Modified Release
Disintegrants & Superdisintegrants
Thickeners and Stabilizers
Direct Compression
Granulation
Lubricants & Glidants
Solubilizers
Co-Processed Excipients
Taste Masking
Film Formers & Plasticizers
Chewable & Orodispersible Aids
API Stability Enhancers
Topical
Empty Capsules
Emulsifying Agents
Vegetarian Capsules
Rheology Modifiers
Parenteral
Surfactant & Foaming Agents
Coloring Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
62
PharmaCompass offers a list of Acamprosate Calcium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Acamprosate Calcium manufacturer or Acamprosate Calcium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Acamprosate Calcium manufacturer or Acamprosate Calcium supplier.
A AKOS015895192 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AKOS015895192, including repackagers and relabelers. The FDA regulates AKOS015895192 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AKOS015895192 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AKOS015895192 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A AKOS015895192 supplier is an individual or a company that provides AKOS015895192 active pharmaceutical ingredient (API) or AKOS015895192 finished formulations upon request. The AKOS015895192 suppliers may include AKOS015895192 API manufacturers, exporters, distributors and traders.
click here to find a list of AKOS015895192 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A AKOS015895192 DMF (Drug Master File) is a document detailing the whole manufacturing process of AKOS015895192 active pharmaceutical ingredient (API) in detail. Different forms of AKOS015895192 DMFs exist exist since differing nations have different regulations, such as AKOS015895192 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A AKOS015895192 DMF submitted to regulatory agencies in the US is known as a USDMF. AKOS015895192 USDMF includes data on AKOS015895192's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AKOS015895192 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of AKOS015895192 suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a AKOS015895192 Drug Master File in Korea (AKOS015895192 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of AKOS015895192. The MFDS reviews the AKOS015895192 KDMF as part of the drug registration process and uses the information provided in the AKOS015895192 KDMF to evaluate the safety and efficacy of the drug.
After submitting a AKOS015895192 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their AKOS015895192 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of AKOS015895192 suppliers with KDMF on PharmaCompass.
A AKOS015895192 CEP of the European Pharmacopoeia monograph is often referred to as a AKOS015895192 Certificate of Suitability (COS). The purpose of a AKOS015895192 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of AKOS015895192 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of AKOS015895192 to their clients by showing that a AKOS015895192 CEP has been issued for it. The manufacturer submits a AKOS015895192 CEP (COS) as part of the market authorization procedure, and it takes on the role of a AKOS015895192 CEP holder for the record. Additionally, the data presented in the AKOS015895192 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the AKOS015895192 DMF.
A AKOS015895192 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. AKOS015895192 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of AKOS015895192 suppliers with CEP (COS) on PharmaCompass.
A AKOS015895192 written confirmation (AKOS015895192 WC) is an official document issued by a regulatory agency to a AKOS015895192 manufacturer, verifying that the manufacturing facility of a AKOS015895192 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting AKOS015895192 APIs or AKOS015895192 finished pharmaceutical products to another nation, regulatory agencies frequently require a AKOS015895192 WC (written confirmation) as part of the regulatory process.
click here to find a list of AKOS015895192 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AKOS015895192 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AKOS015895192 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AKOS015895192 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AKOS015895192 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AKOS015895192 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AKOS015895192 suppliers with NDC on PharmaCompass.
AKOS015895192 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AKOS015895192 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right AKOS015895192 GMP manufacturer or AKOS015895192 GMP API supplier for your needs.
A AKOS015895192 CoA (Certificate of Analysis) is a formal document that attests to AKOS015895192's compliance with AKOS015895192 specifications and serves as a tool for batch-level quality control.
AKOS015895192 CoA mostly includes findings from lab analyses of a specific batch. For each AKOS015895192 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AKOS015895192 may be tested according to a variety of international standards, such as European Pharmacopoeia (AKOS015895192 EP), AKOS015895192 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AKOS015895192 USP).
